Wpływ spożywania kawy na organizm człowieka

Coffee represents an exceptionally low-calorie beverage, with 100 milliliters of unadulterated infusion supplying the body with merely approximately two kilocalories—provided no supplementary ingredients such as milk, cream, or sugar have been incorporated. Its biochemical composition encompasses a diverse array of macronutrient fractions, including trace amounts of simple carbohydrates, minimal plant-derived proteins, and negligible lipid concentrations. Furthermore, coffee serves as a valuable source of water-soluble B-complex vitamins—most notably nicotinic acid (vitamin B3)—alongside essential electrolytes such as potassium, which governs fluid-electrolyte balance, and magnesium, which supports neurological function. Of paramount scientific interest is the fact that coffee beans contain over one thousand identified bioactive compounds, among which the purine-based alkaloid caffeine (with psychoactive properties), chlorogenic acid polyphenols exhibiting antioxidant capacity, diterpenes (including kahweol and cafestol, which may influence lipid metabolism), organic carboxylic acids (such as malic acid, phosphoric acid V, and citric acid), hydroxycinnamic acid (caffeic acid) with anti-inflammatory effects, and tannins (which modify flavor profiles and the bioavailability of other constituents) are particularly noteworthy. The ultimate nutritional and bioactive profile of the coffee brew undergoes substantial variation depending on agronomic factors (e.g., *Coffea arabica* vs. *Coffea canephora* species), plantation microclimate, soil mineral composition, ripeness of coffee cherries at harvest, post-harvest processing methods (dry vs. wet), roasting degree (ranging from light to dark), and extraction parameters (water temperature, steeping duration, grind coarseness).

The caffeine found in coffee exerts a vasodilatory effect—it widens the lumen of blood vessels, thereby enhancing blood circulation, stimulating the central nervous system, and significantly improving concentration abilities. However, the benefits of this beverage extend far beyond cognitive enhancement. Research indicates that coffee may also accelerate metabolic rate (Tofalo et al., 2016). The chlorogenic acid present in coffee beans exhibits multifaceted properties: it functions as a potent antioxidant, demonstrates antimicrobial activity (against bacteria, viruses, and fungi), and possesses potential anticancer effects. Furthermore, this compound inhibits the absorption of fatty acids within the gastrointestinal tract and contributes to reductions in triglyceride levels as well as low-density lipoprotein (LDL) cholesterol (Gökçen & Sanlier, 2019). Regular coffee consumption is associated with the prevention of numerous conditions, including cardiovascular diseases, malignant neoplasms, and type 2 diabetes mellitus. A meta-analysis conducted by Poole and colleagues (2018), encompassing 218 studies, revealed that daily intake of three cups of coffee substantially lowers the risk of mortality due to cardiovascular disorders or cancer. An additional fourth cup per day further decreases this risk by 4%—an effect observed with both caffeinated and decaffeinated varieties. Moreover, consistent consumption of this beverage yields benefits in the context of metabolic syndrome, gallstones and kidney stones, gout, and liver diseases.

On the one hand, drinking 3 cups of coffee a day is associated with a lower risk of death from cardiovascular disease (19%), including coronary heart disease. Consuming 3 to 5 cups a day reduces the likelihood of coroner's disease and stroke. Positive effects of coffee on heart disease are due to the presence of chlorogenic acid and other bioactive compounds. However, these compounds reduce the risk of heart disease (by 19%), improve the condition of the central nervous system, and increase the level of nitric oxide in the blood vessels of the arteries (M. Pelinska, P. Boginska, 2019) which increases blood pressure.

According to the most recent classifications by the International Agency for Research on Cancer (IARC), coffee has been formally designated as a substance whose regular consumption does not demonstrate carcinogenic effects in humans. Furthermore, extensive meta-analyses confirm that the biologically active compounds present in coffee—including chlorogenic acid, a potent antioxidant; caffeic acid, which modulates apoptotic pathways in malignant cells; and diterpenes (such as kahweol and cafestol) that enhance detoxifying enzymatic activity—exhibit significant protective effects against multiple cancer types. Chlorogenic acid scavenges reactive oxygen species (ROS) and mitigates oxidative DNA damage, whereas caffeic acid promotes programmed cell death in tumor cells by regulating the cell cycle (Pelczyńska & Bogdański, 2019). Epidemiological evidence indicates a statistically significant reduction in the risk of prostate cancer, endometrial carcinoma, oral and pharyngeal cancers, malignant melanoma, and leukemia among regular coffee consumers. Conversely, no association has been established between coffee intake and decreased incidence rates of gastrointestinal cancers (stomach, colon, rectum), ovarian cancer, thyroid cancer, pancreatic cancer, esophageal cancer, laryngeal cancer, non-Hodgkin lymphoma, or glioblastoma (Poole et al., 2017). Notably, coffee’s effects on lung cancer risk exhibit a dual pattern: in smokers, its consumption may exacerbate susceptibility, whereas in non-smokers, it correlates with an 8% reduction in disease risk, suggesting a complex interaction between coffee constituents and nicotine metabolites (Poole et al., 2017).

Caffeine, chlorogenic acid and magnesium are key components of coffee that improve the parameters of carbohydrate economy. They improve glucose and insulin metabolism. They have a positive effect on gut absorption and glucose use in the body and increase cell sensitivity to insulin (M. Pelczyńska and P. Bogdański 2019). Coffee consumption is associated with a lower risk of developing type 2 diabetes.

Emerging epidemiological evidence strongly suggests that habitual coffee intake may serve as a meaningful protective factor against a spectrum of hepatic pathologies. According to a comprehensive meta-analysis conducted by Poole and colleagues in 2017, even modest daily consumption of this beverage is associated with statistically significant reductions in the risk of developing: non-alcoholic steatohepatitis (a 29% decrease), progressive hepatic fibrosis (a 27% reduction), and cirrhosis—the most severe manifestation of chronic liver failure (a 39% lowering of incidence). These hepatoprotective mechanisms are hypothesized to involve antioxidant activity, modulation of glucose metabolism, and suppression of inflammatory pathways within hepatic tissue.

Emerging scientific evidence substantiates that habitual coffee consumption may exert beneficial effects on central nervous system functionality. The primary bioactive compound—caffeine—serves as a neuromodulator, thereby exhibiting potential prophylactic properties against neurodegenerative disorders. A meta-analysis conducted by Costa et al. (2010) revealed that individuals consuming an average of three cups of coffee daily demonstrate a statistically significant 25% reduction in the risk of developing Parkinson’s disease compared to non-coffee drinkers. Furthermore, data compiled by Nehlig (2016) indicate that moderate intake (2–3 cups per day) correlates with a 15% decrease in the incidence of depressive episodes, suggesting multifaceted health-promoting attributes of this beverage.

Extensive scientific research confirms that the regular consumption of coffee—particularly when prepared as black, filtered coffee without the addition of sugar, milk, or cream—may yield measurable benefits in both the prevention and adjunctive management of a broad spectrum of chronic conditions. Among the most significant are type 2 diabetes and insulin resistance, various malignant neoplasms, neurodegenerative disorders (including Alzheimer’s and Parkinson’s diseases), and hepatic dysfunctions such as fatty liver disease and cirrhosis. These health-promoting effects are primarily attributable to polyphenolic compounds, notably chlorogenic acids, alongside other biologically active metabolites that exhibit well-documented antioxidant and anti-inflammatory properties within the human body.